Notably, a serum MMP-7 level exceeding 1.43 ng/mL demonstrated an 88% diagnostic accuracy for predicting BA in children presenting with CS, suggesting its potential as a non-invasive biomarker22. This evidence concerns the gene MMP7 and Cowden syndrome 1.